For professionals creating a clinical pathway for a disease state, it is important to understand the various stakeholder biases in real-world contexts, so that appropriate prompts may be integrated into the pathway in order to achieve the best outcomes.
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Clinical pathways have begun including financial and accountable outcome measures. As we go into 2018, these issues are expected to undergo major changes as a result of legislation and regulations coming out of Washington.
As a retail provider, CVS not only has its pharmacies, which have prescribing authority in several states and can act as treatment providers in certain areas, such as vaccination. It also has the ability to operate clinics in many locations.
Using clinical pathways to direct exactly where and when care can be best provided is critical to population health management success.
Should the Trump administration succeed in rolling back many ACA key policies, clinical pathways will need to mitigate the costs from patients, providers and payers.
The author highlights the potential benefits of prescribing specific sites of care in clinical pathways.